Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase

被引:43
|
作者
Sonar, Vijay P. [1 ]
Corona, Angela [2 ]
Distinto, Simona [1 ]
Maccioni, Elias [1 ]
Meleddu, Rita [1 ]
Fois, Benedetta [1 ]
Floris, Costantino [3 ]
Malpure, Nilesh V. [4 ]
Alcaro, Stefano [5 ]
Tramontano, Enzo [2 ]
Cottiglia, Filippo [1 ]
机构
[1] Univ Cagliari, Drug Sci Sect, Dept Life & Environm Sci, Via Osped 72, I-09124 Cagliari, Italy
[2] Univ Cagliari, Dept Life & Environm Sci, Cittadella Monserrato SS554, I-09042 Cagliari, Italy
[3] Univ Cagliari, Dipartimento Sci Chim, I-09042 Cagliari, Italy
[4] SSGM Coll, Dept Bot, IN-423601 Kopargaon, MS, India
[5] Magna Graecia Univ Catanzaro, Dipartimento Sci Salute, Campus S Venuta,Viale Europa, I-88100 Catanzaro, Italy
关键词
Ocimum sanctum; HIV-1; RNase H; Reverse transcriptase; Triterpenes; Ferulic acid derivatives; RIBONUCLEASE H ACTIVITY; MOLECULAR-MECHANICS; BINDING-AFFINITY; ACTIVE-SITE; RNASE-H; DERIVATIVES; IDENTIFICATION; PARAMETERS; RECEPTORS; DISCOVERY;
D O I
10.1016/j.ejmech.2017.02.054
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Using an HIV-1 Reverse Transcriptase (RT)-associated RNase H inhibition assay as lead, bioguided fractionation of the dichloromethane extract of the Ocimum sanctum leaves led to the isolation of five triterpenes (1-5) along with three 3-methoxy-4-hydroxy phenyl derivatives (6-8). The structure of this isolates were determined by 1D and 2D NMR experiments as well as ESI-MS. Tetradecyl ferulate (8) showed an interesting RNase H IC50 value of 12.4 mu M and due to the synthetic accessibility of this secondary metabolite, a structure-activity relationship study was carried out. A series of esters and amides of ferulic and caffeic acids were synthesized and, among all, the most active was N-oleylcaffeamide displaying a strong inhibitory activity towards both RT-associated functions, ribonuclease H and DNA polymerase. Molecular modeling studies together with Yonetani-Theorell analysis, demonstrated that Noleylcaffeamide is able to bind both two allosteric site located one close to the NNRTI binding pocket and the other close to RNase H catalytic site. (C) 2017 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:248 / 260
页数:13
相关论文
共 50 条
  • [11] HIV-1 reverse transcriptase resistance to nonnucleoside inhibitors
    Spence, RA
    Anderson, KS
    Johnson, KA
    BIOCHEMISTRY, 1996, 35 (03) : 1054 - 1063
  • [12] SPECIFIC HIV-1 REVERSE-TRANSCRIPTASE INHIBITORS
    DEBYSER, Z
    PAUWELS, R
    ANDRIES, K
    DE CLERCQ, E
    JOURNAL OF ENZYME INHIBITION, 1992, 6 (01): : 47 - 53
  • [13] Recent discoveries in HIV-1 reverse transcriptase inhibitors
    Gu, Shuang-Xi
    Zhu, Yuan-Yuan
    Wang, Chao
    Wang, Hai-Feng
    Liu, Gen-Yan
    Cao, Shuang
    Huang, Lu
    CURRENT OPINION IN PHARMACOLOGY, 2020, 54 : 166 - 172
  • [14] A Search for Dual Action HIV-1 Reverse Transcriptase, Bacterial RNA Polymerase Inhibitors
    Paneth, Agata
    Fraczek, Tomasz
    Grzegorczyk, Agnieszka
    Janowska, Dominika
    Malm, Anna
    Paneth, Piotr
    MOLECULES, 2017, 22 (11):
  • [15] Evolution of HIV-1 reverse transcriptase and integrase dual inhibitors: Recent advances and developments
    Gill, Muhammad Shoaib Ali
    Hassan, Sharifah Syed
    Ahemad, Nafees
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 179 : 423 - 448
  • [16] Oligonucleotide Inhibitors of HIV-1 Integrase Efficiently Inhibit HIV-1 Reverse Transcriptase
    Korolev, S. P.
    Zatsepin, T. S.
    Gottikh, M. B.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2017, 43 (02) : 135 - 139
  • [17] Oligonucleotide inhibitors of HIV-1 integrase efficiently inhibit HIV-1 reverse transcriptase
    S. P. Korolev
    T. S. Zatsepin
    M. B. Gottikh
    Russian Journal of Bioorganic Chemistry, 2017, 43 : 135 - 139
  • [18] Synthesis and evaluation of quinoxalinones as HIV-1 reverse transcriptase inhibitors
    Patel, M
    McHugh, RJ
    Cordova, BC
    Klabe, RM
    Erickson-Viitanen, S
    Trainor, GL
    Rodgers, JD
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (15) : 1729 - 1731
  • [19] OLIGONUCLEOTIDE CONJUGATES AS INHIBITORS OF HIV-1 INTEGRASE AND REVERSE TRANSCRIPTASE
    Zatsepin, T.
    Agapkina, J.
    Korolev, S.
    Gottikh, M.
    NUCLEIC ACID THERAPEUTICS, 2011, 21 (05) : A31 - A31
  • [20] Peptides as new inhibitors of HIV-1 reverse transcriptase and integrase
    de Soultrait, VR
    Desjobert, C
    Tarrago-Litvak, L
    CURRENT MEDICINAL CHEMISTRY, 2003, 10 (18) : 1765 - 1778